Wakefield Asset Management LLLP Makes New $3.32 Million Investment in Corteva, Inc. $CTVA

Wakefield Asset Management LLLP bought a new stake in Corteva, Inc. (NYSE:CTVA) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 49,101 shares of the company’s stock, valued at approximately $3,321,000.

A number of other hedge funds have also made changes to their positions in CTVA. Activest Wealth Management grew its position in Corteva by 118.3% during the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after purchasing an additional 200 shares in the last quarter. True Wealth Design LLC increased its stake in Corteva by 209.5% in the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after buying an additional 264 shares during the period. Total Investment Management Inc. purchased a new stake in Corteva in the 2nd quarter worth approximately $27,000. Twin Peaks Wealth Advisors LLC acquired a new stake in shares of Corteva during the 2nd quarter valued at $29,000. Finally, Redmont Wealth Advisors LLC purchased a new position in shares of Corteva during the 3rd quarter valued at $29,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider directly owned 8,090 shares in the company, valued at approximately $619,289.50. The trade was a 50.67% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.15% of the company’s stock.

Corteva Trading Down 2.6%

Shares of NYSE:CTVA opened at $76.30 on Wednesday. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $51.31 billion, a PE ratio of 48.29, a P/E/G ratio of 2.68 and a beta of 0.72. Corteva, Inc. has a 1 year low of $53.40 and a 1 year high of $80.90. The firm has a fifty day moving average price of $73.40 and a 200 day moving average price of $69.06.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting the consensus estimate of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. During the same period last year, the company earned $0.32 earnings per share. The business’s revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts expect that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is presently 45.57%.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. Jefferies Financial Group upped their price target on shares of Corteva from $85.00 to $95.00 and gave the stock a “buy” rating in a research note on Monday, March 2nd. Citigroup boosted their target price on Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a research note on Thursday, February 5th. Royal Bank Of Canada upped their target price on Corteva from $80.00 to $89.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Oppenheimer set a $86.00 price target on Corteva in a report on Thursday, February 5th. Finally, Wells Fargo & Company boosted their price target on Corteva from $77.00 to $85.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat, Corteva presently has an average rating of “Moderate Buy” and a consensus target price of $82.90.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.